Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Risks and Benefits of Preexposure and Postexposure Smallpox Vaccination1
  • Published Date:
    Nov 2003
  • Source:
    Emerg Infect Dis. 9(11):1363-1370.
  • Language:
Filetype[PDF-700.34 KB]


Details:
  • Alternative Title:
    Emerg Infect Dis
  • Personal Author:
    Meltzer, Martin I.
  • Description:
    This article presents a model and decision criteria for evaluating a person's risk of pre- or postexposure smallpox vaccination in light of serious vaccine-related adverse events (death, postvaccine encephalitis and progressive vaccinia). Even at a 1-in-10 risk of 1,000 initial smallpox cases, a person in a population of 280 million has a greater risk for serious vaccine-related adverse events than a risk for smallpox. For a healthcare worker to accept preexposure vaccination, the risk for contact with an infectious smallpox case-patient must be >1 in 100, and the probability of 1,000 initial cases must be >1 in 1,000. A member of an investigation team would accept preexposure vaccination if his or her anticipated risk of contact is 1 in 2.5 and the risk of attack is assumed to be >1 in 16,000. The only circumstances in which postexposure vaccination would not be accepted are the following: if vaccine efficacy were <1%, the risk of transmission were <1%, and (simultaneously) the risk for serious vaccine-related adverse events were >1 in 5,000.
  • Subject:
  • Document Type:
    Journal Article
  • Place as Subject:
    United States
  • Collection(s):
    Emerging Infectious Diseases
  • Main Document Checksum:
No Related Documents.
You May Also Like:
  1. Weekly cases of notifiable diseases, United States, U.S. territories, and Non-U.S. Residents weeks ending August 1, 2020 (Week 31) Table1gg Spotted fever rickettsiosis; Smallpox
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System.
    Published Date:
    08/06/2020
    Series:
    National Notifiable Diseases: Infectious Weekly Tables 2020 week 31
    Description:
    2020-31-Table1gg -H.pdf
    File Type:
    Filetype[PDF - 98.18 KB]
  2. Public health guidance for community-related exposure
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Published Date:
    July 31, 2020
    Series:
    Coronavirus Disease 2020 (COVID-19)
    Get and keep America open
    Description:
    Updated July 31, 2020The following guidance is provided for definitions and management of contacts of people with COVID-19. Separate guidance is available for international travelers. Healthcare personnel (HCP) should follow CDC’s Interim U.S. Guid...
    File Type:
    Filetype[PDF - 633.74 KB]
  3. Weekly cases of notifiable diseases, United States, U.S. territories, and Non-U.S. Residents weeks ending July 25, 2020 (Week 30) Table1gg Spotted fever rickettsiosis; Smallpox
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System.
    Published Date:
    07/31/2020
    Series:
    National Notifiable Diseases: Infectious Weekly Tables 2020 week 30
    Description:
    2020-30-Table1gg -H.pdf
    File Type:
    Filetype[PDF - 98.22 KB]
  4. Weekly cases of notifiable diseases, United States, U.S. territories, and Non-U.S. Residents weeks ending July 18, 2020 (Week 29) Table1gg Spotted fever rickettsiosis; Smallpox
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System.
    Published Date:
    07/23/2020
    Series:
    National Notifiable Diseases: Infectious Weekly Tables 2020 week 29
    Description:
    2020-29-Table1gg -H.pdf
    File Type:
    Filetype[PDF - 98.17 KB]
  5. Detection and Genetic Characterization of Community-Based SARS-CoV-2 Infections — New York City, March 2020
    Personal Author:
    Bushman, Dena; Alroy, Karen A.; Greene, Sharon K.; Keating, Page; Wahnich, Amanda; Weiss, Don; Pathela, Preeti; Harrison, Christy; Rakeman, Jennifer; Langley, Gayle; Tong, Suxiang; Tao, Ying; Uehara, Anna; Queen, Krista; Paden, Clinton R.; Szymczak, Wendy; Orner, Erika P.; Nori, Priya; Lai, Phi A.; Jacobson, Jessica L.; Singh, Harjot K.; Calfee, David P.; Westblade, Lars F.; Vasovic, Ljiljana V.; Rand, Jacob H.; Liu, Dakai; Singh, Vishnu; Burns, Janice; Prasad, Nishant; Sell, Jessica;
    Corporate Authors:
    CDC COVID-19 Surge Laboratory Group;
    Published Date:
    July 17 2020
    Source:
    MMWR Morb Mortal Wkly Rep. 69(28):918-922
    Description:
    To limit introduction of SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), the United States restricted travel from China on February 2, 2020, and from Europe on March 13. To determine whether local transmission of SARS-CoV-2 cou...
    File Type:
    Filetype[PDF - 241.46 KB]